Cite
MLA Citation
Christian Buske et al.. “Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.” Journal of clinical oncology, vol. 40, no. 1, 2022, pp. 52–62. http://access.bl.uk/ark:/81055/vdc_100150610394.0x000036